Nicolas Mathis (@nicopmat) 's Twitter Profile
Nicolas Mathis

@nicopmat

Postdoctoral Researcher @ University of Zurich (Schwank Lab) | Crafting Genomes with CRISPR | Intersecting Bioinformatics & ML through Multi-Omics

ID: 1162482227109924864

calendar_today16-08-2019 21:52:55

196 Tweet

253 Followers

206 Following

Gerald Schwank (@schwanklab) 's Twitter Profile Photo

If you want to know the outcome of your prime editing experiment before you even conducted the experiment, visit pridict.it Congrats to Nicolas and many thanks to all collaborators Krauthammer Lab Bas van Steensel lab

tommaso patriarchi (@tpatriarchi) 's Twitter Profile Photo

Our new sensor for the neuropeptide #nociceptin is now out in Nature Communications Fantastic teamwork with the mbruchas lab and many other super collabs! Very proud of our student Xuehan for her PhD work! Check it out: rdcu.be/dLO3m 😉

Joana Ferreira da Silva (@ferreirasilvaj) 's Twitter Profile Photo

Thrilled to see our click editing paper out today in Nature Biotechnology! 🚀 Click Editors (CEs) are a new class of genome writers which combine DNA polymerases and HUH endonucleases with RNA-programmable nickases for precise edits without DNA DSBs🧬✨ nature.com/articles/s4158…

Nicolas Mathis (@nicopmat) 's Twitter Profile Photo

Bridging genome editing, protein engineering, and applied machine learning in biology: Great to see our latest study, spearheaded by Kim Fabiano Marquart, out today in Nature Methods. Check out the paper! 🧬💻 UZH Science Gerald Schwank Krauthammer Lab nature.com/articles/s4159…

University of Zurich (@uzh_en) 's Twitter Profile Photo

TnpB is much smaller than the well-known CRISPR-Cas "gene scissors". The tool for targeted modification of the genome has now been improved to such an extent that it could one day be used to treat a genetic defect that leads to a lifelong high cholesterol level.

TnpB is much smaller than the well-known CRISPR-Cas "gene scissors". The tool for targeted modification of the genome has now been improved to such an extent that it could one day be used to treat a genetic defect that leads to a lifelong high cholesterol level.